- Q1 2024 Lucid Diagnostics Inc Earnings Call TranscriptMay 13, 2024$0.95 (+0.59%)Earnings
- Q4 2023 Lucid Diagnostics Inc Earnings Call TranscriptMar 26, 2024$0.99 (-6.60%)Earnings
- Q3 2023 Lucid Diagnostics Inc Earnings Call TranscriptNov 14, 2023$1.3 (+12.07%)Earnings
- Q2 2023 Lucid Diagnostics Inc Earnings Call TranscriptAug 15, 2023$1.49 (+0.34%)Earnings
- Lucid Diagnostics Inc Annual Shareholders Meeting TranscriptJun 21, 2023
- Q4 2022 Lucid Diagnostics Inc Earnings Call TranscriptMar 14, 2023$1.72 (+6.83%)Earnings
- PAVmed Inc, Lucid Diagnostics Inc and Veris Health Inc Strategic Business Update Call TranscriptJan 17, 2023
- Q3 2022 Lucid Diagnostics Inc Earnings Call TranscriptNov 14, 2022$2.27 (+1.79%)Earnings
- Q2 2022 Lucid Diagnostics Inc Earnings Call TranscriptAug 15, 2022$3.35 (-1.18%)Earnings
- Lucid Diagnostics Inc Annual Shareholders Meeting TranscriptJun 21, 2022
- Q1 2022 Lucid Diagnostics Inc Earnings Call TranscriptMay 11, 2022$1.86 (-7.46%)Earnings
- Lucid Diagnostics Inc at Needham Healthcare Conference (Virtual) TranscriptApr 12, 2022
Q2 2022 Lucid Diagnostics Inc Earnings Call Transcript
Greetings, and welcome to Lucid Diagnostics Second Quarter 2022 Business Update Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
I'd now like to turn the conference over to your host, Adrian Miller. Please proceed, sir.
Thank you, operator.
Good afternoon, everyone. This is Adrian Miller, Vice President of Investor Relations at Lucid Diagnostics. Thank you for participating in today's business update call. Joining me today on the call are Dr. Lishan Aklog, Chairman and CEO of Lucid Diagnostics, along with Dennis McGrath, the Chief Financial Officer of Lucid Diagnostics.
The press release announcing our business update and financial results is available on Lucid's website. Please take a moment to read the disclaimer about the forward-looking statements in the press release. The business update press release and this conference call, both include forward-looking statements, and these forward-looking statements are subject to known and unknown
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)